Michele A. Anderson
CIK: 0002141644
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BRVE
Braveheart Bio, Inc.
Officer
Discretionary Trading P&L
Holdings
About Anderson Michele A.
Anderson Michele A. (SEC CIK 0002141644) files insider reports with the SEC as Chief Development Officer of Braveheart Bio, Inc. (BRVE).
Signal8 holds 2 ownership filings by Anderson Michele A. (1 Form 3, 1 Form 4), filed between Aug 5, 2026 and Aug 7, 2026. Those filings report 2 transactions, from Aug 5, 2026 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Anderson Michele A.'s filings is in SAN FRANCISCO, CA.
Recent filings by Anderson Michele A.
Other insiders filing for Braveheart Bio, Inc. (BRVE)
- Agarwala Vineeta, Director
- AH Bio Fund IV, L.P., 10% Owner
- Chimovits Erez, Director
- ORBIMED ADVISORS LLC, Director
- Jiangsu Hengrui Pharmaceuticals Co., Ltd., 10% Owner
- Forbion Growth Opportunities Fund III Cooperatief U.A., 10% Owner